64 results
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
a beneficial owner of our common stock that is, (or other entity classified as a partnership for U.S. federal income tax purposes:
(a) an individual who
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
, a “U.S. Holder” means a beneficial owner of our common stock that is, (or other entity classified as a partnership for U.S. federal income tax
8-K
EX-10.1
bubmi
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
sm3c6qs
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
kgtml3d0jx4 50h
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
1dw2q
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
xr6la 8a79l5kpvgx
28 Mar 22
Prospectus supplement for primary offering
4:53pm